Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gregory Piazza, M.D.


This page shows the publications co-authored by Gregory Piazza and Umberto Campia.
Connection Strength

  1. Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO Trial. Thromb Haemost. 2021 Sep 16.
    View in: PubMed
    Score: 0.240
  2. Impact of Atrial Fibrillation on In-Hospital Mortality and Stroke in Acute Aortic Syndromes. Am J Med. 2021 11; 134(11):1419-1423.
    View in: PubMed
    Score: 0.237
  3. Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19. J Am Coll Cardiol. 2020 11 03; 76(18):2060-2072.
    View in: PubMed
    Score: 0.226
  4. Peripheral Artery Disease: Past, Present, and Future. Am J Med. 2019 10; 132(10):1133-1141.
    View in: PubMed
    Score: 0.204
  5. Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis. Blood Adv. 2021 12 14; 5(23):5283-5289.
    View in: PubMed
    Score: 0.061
  6. Images in Vascular Medicine: Pulmonary embolism and acute aortic syndromes - Double trouble when vascular medicine emergencies meet. Vasc Med. 2022 02; 27(1):97-99.
    View in: PubMed
    Score: 0.059
  7. Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications. Am J Med. 2018 12; 131(12):1408-1417.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.